908 Devices Inc.

NASDAQ:MASS

Medical - Devices

Healthcare
$9.52 +2.51%

+$0.22 today

Market cap
$395.86M
Beta
0.64
P/E (TTM)
-9.0
EPS (TTM)
-$0.97
52W Low $5.03High $9.34

Volume 0.25M

Average 0.27M

MASS Sales of Investments

Cash received from selling or redeeming investments.

908 Devices Inc.NASDAQ: MASS

Sales of Investments · Q1 FY2026 · quarter ended Mar 2026

Sales of investments growth accelerates

Q1 FY2026 sales of investments of $16.4M rose 236.3% year over year, ahead of the +19.4% change in trailing-twelve-month sales of investments. Sequentially, it fell 0.8% from the prior quarter.

Context

  • Sales of investments amounted to 85.1% of revenue in FY2025, down 6.4 pp from a year earlier.
  • Sales of investments increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +236.3% holds above the trailing-twelve-month pace of +19.4%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$16.4M-0.8% QoQ
Last fiscal yearDec 2025
$47.8M-12.4% YoY
LTMMar 2026
$59.32M+19.4% YoY
Sales of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+236.3%——
1 year-12.4%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Sales of Investments history

USD · from the cash flow

Latest · FY2025
47.8M USD
Year-over-year change
-12.4%

Sales of Investments vs competitors

How MASS compares with its peers on the latest reported figures

  • MASS's LTM Mar 2026 sales of investments of $59.32M is the 2nd largest of the 3 companies compared; the peer median is $228.65M.
  • Its year-over-year change of +19.4% is the highest of 3, against a peer median of -37.5%.
  • Sales of investments amounts to 102.6% of revenue for MASS, versus a peer median of 10.8%.
MASS Competitors Peer median
Sales of Investments for MASS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
QGENQiagen N.V.LTM Jun 2026$454.29M -35.0%-12.2%21.6%
MASS908 Devices Inc.LTM Mar 2026$59.32M +19.4%—102.6%
AAgilent Technologies, Inc.LTM Jul 2026$3M -40.0%-28.6%0.0%
Peer median (excluding MASS) $228.65M-37.5%-20.4%10.8%

Competitors are the stored peer set for MASS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(22.17M)(33.56M)(36.4M)(72.21M)19.49M
Depreciation & Amortization925K1.61M2.38M4.68M3.83M
Deferred Income Tax0(129K)(305K)(283K)0
Stock-Based Compensation2.5M7.21M9.79M11.76M9.85M
Change in Working Capital(12.44M)3.36M(1.57M)(2.54M)(15.3M)
Accounts Receivables(11.28M)5.93M680K(2.93M)220K
Inventory(4.48M)(5.48M)(3.9M)(1.66M)(3.73M)
Accounts Payables2.75M000(5.93M)
Other Working Capital567K2.9M1.65M2.05M(5.86M)
Other Non-Cash Items2.09M584K1.05M28.34M(41.55M)
Operating Cash Flow(29.08M)(20.93M)(25.06M)(30.25M)(23.69M)
Capital Expenditures(737K)(2.05M)(2.05M)(602K)(955K)
Acquisitions (Net)0(13.76M)0(44.78M)(2M)
Purchases of Investments00(48.87M)(55.5M)(64.01M)
Sales of Investments0024.52M54.56M47.8M
Other Investing Activities000069.91M
Investing Cash Flow(737K)(15.81M)(26.4M)(46.32M)50.75M
Debt Repayment(39K)0(15M)00
Common Stock Issued852K1.55M936K1.15M864K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities93.91M(374K)(1.87M)(1.52M)(1.56M)
Financing Cash Flow94.73M1.18M(15.94M)(376K)(697K)
Effect of Forex Changes018K13K(65K)27K
Net Change in Cash64.91M(35.54M)(67.38M)(77.01M)26.39M
Free Cash Flow(29.82M)(22.98M)(27.1M)(30.85M)(24.64M)

908 Devices Inc.

NASDAQ:MASS

Intrinsic Alpha fair value

Locked

Current Price

$9.52

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.